LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 79 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2019. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,000 | -90.5% | 432 | -91.7% | 0.00% | – |
| Q4 2020 | $21,000 | +61.5% | 5,222 | +56.7% | 0.00% | – |
| Q3 2020 | $13,000 | -23.5% | 3,332 | -14.6% | 0.00% | – |
| Q2 2020 | $17,000 | +30.8% | 3,903 | +56.1% | 0.00% | – |
| Q1 2020 | $13,000 | -58.1% | 2,500 | -68.5% | 0.00% | – |
| Q4 2019 | $31,000 | -50.8% | 7,933 | +11.7% | 0.00% | – |
| Q3 2019 | $63,000 | -3.1% | 7,103 | +0.9% | 0.00% | – |
| Q2 2019 | $65,000 | +80.6% | 7,043 | +27.2% | 0.00% | – |
| Q1 2019 | $36,000 | +620.0% | 5,537 | +901.3% | 0.00% | – |
| Q4 2018 | $5,000 | +66.7% | 553 | +273.6% | 0.00% | – |
| Q3 2018 | $3,000 | -25.0% | 148 | -2.6% | 0.00% | – |
| Q2 2018 | $4,000 | -98.9% | 152 | -98.6% | 0.00% | – |
| Q3 2017 | $379,000 | +6216.7% | 10,899 | +5349.5% | 0.00% | – |
| Q2 2017 | $6,000 | -93.5% | 200 | -93.5% | 0.00% | – |
| Q1 2017 | $93,000 | -15.5% | 3,100 | -74.2% | 0.00% | – |
| Q2 2014 | $110,000 | +1.9% | 12,000 | +20.0% | 0.00% | – |
| Q1 2014 | $108,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 240,000 | $1,027,000 | 95.09% |
| TANG CAPITAL MANAGEMENT LLC | 10,049,224 | $43,011,000 | 8.56% |
| RTW INVESTMENTS, LP | 2,327,903 | $9,963,000 | 0.15% |
| Boxer Capital, LLC | 890,700 | $3,812,000 | 0.13% |
| Tibra Equities Europe Ltd | 72,600 | $311,000 | 0.10% |
| WealthTrust Axiom LLC | 25,400 | $108,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 52,749 | $226,000 | 0.02% |
| FIRST MIDWEST BANK TRUST DIVISION | 34,231 | $147,000 | 0.02% |
| HOLLENCREST CAPITAL MANAGEMENT | 42,355 | $181,000 | 0.02% |
| Summit Global Investments | 48,500 | $208,000 | 0.01% |